Inventor · disambiguated record
Sajeev Chandran
Also filed as: CHANDRAN SAJEEV
7 granted patents·17 pending applications·38 citations·filing 2010–2024
79Inventor score
Files withLUPIN LTD8LUPIN ATLANTIS HOLDINGS SA5BHUTADA PRAVIN MEGHRAJJI4DESHMUKH ASHISH ASHOKRAO4HOWARD WILLIAM WAYNE2
Top patents by PatentIndex Score
24 records- 0191US9884022B2Controlled release pharmaceutical compositions of tapentadolDESHMUKH ASHISH ASHOKRAO·Filed 2011·Granted Feb 6, 2018·27 cites·7 claims
- 0282US8614210B2Process for preparing pharmaceutical ophthalmic compositionsBHUTADA PRAVIN MEGHRAJJI·Filed 2010·Granted Dec 24, 2013·8 cites·9 claims
- 0374US8617602B2Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environmentsHOWARD WILLIAM WAYNE·Filed 2012·Granted Dec 31, 2013·3 cites·9 claims
- 0461US2024350480A1Stable pharmaceutical composition of methylnaltrexone for an oral administrationLUPIN LTD·Filed 2024·Application pending·0 cites
- 0557US10842802B2Controlled release pharmaceutical dosage formsMEDICIS PHARMACEUTICAL CORP·Filed 2013·Granted Nov 24, 2020·0 cites·20 claims
- 0657US2024173272A1Extended-release liquid compositions of mexiletine for oral administrationLUPIN ATLANTIS HOLDINGS SA·Filed 2023·Application pending·0 cites
- 0754US2015150809A1Immediate Release Compositions and Methods For Delivering Drug Formulations Using Weak Acid Ion Exchange Resins In Abnormally High pH EnvironmentsHOWARD WILLIAM WAYNE·Filed 2013·Application pending·0 cites
- 0851US9421165B2Oral controlled release pharmaceutical compositions of bepotastineDESHMUKH ASHISH ASHOKRAO·Filed 2012·Granted Aug 23, 2016·0 cites·16 claims
- 0949US9820936B2Oral controlled release pharmaceutical compositions of BepotastineLUPIN LTD·Filed 2016·Granted Nov 21, 2017·0 cites·17 claims
- 1047US2023201117A1Ophthalmic nanoemulsion compositionsLUPIN LTD·Filed 2021·Application pending·0 cites
- 1144US2015017242A1Bilayer Tablet of DronedaroneLUPIN LTD·Filed 2013·Application pending·0 cites
- 1243US2018098942A1Oral pharmaceutical composition of methylergonovine and methods of use thereofLUPIN ATLANTIS HOLDINGS SA·Filed 2017·Application pending·0 cites
- 1343US2018116952A1Oral pharmaceutical composition of methylergonovine and methods of use thereofLUPIN ATLANTIS HOLDINGS SA·Filed 2017·Application pending·0 cites
- 1443US2018116953A1Oral pharmaceutical composition of methylergonovine and methods of use thereofLUPIN ATLANTIS HOLDINGS SA·Filed 2017·Application pending·0 cites
- 1543US2018098982A1Oral pharmaceutical composition of methylergonovine and methods of use thereofLUPIN ATLANTIS HOLDINGS SA·Filed 2017·Application pending·0 cites
- 1642US2020171124A1Topical compositions for ophthalmic and otic useLUPIN LTD·Filed 2017·Application pending·0 cites
- 1741US2013004545A1Slow release pharmaceutical compositions of iloperidoneLUPIN LTD·Filed 2010·Application pending·0 cites
- 1840US2012027855A1Pharmaceutical compositions for gastrointestinal drug deliveryDESHMUKH ASHISH ASHOKRAO·Filed 2011·Application pending·0 cites
- 1937US10278963B2Pharmaceutical compositions of donepezil having specific in vitro dissolution profile or pharmacokinetics parametersLUPIN LTD·Filed 2014·Granted May 7, 2019·0 cites·27 claims
- 2036US2013323309A1Sustained Release Composition of MemantineBHUTADA PRAVIN MEGHRAJJI·Filed 2012·Application pending·0 cites
- 2135US2016015698A1Pharmaceutical compositions of donepezil having specific in vitro dissolution profile or pharmacokinetics parametersLUPIN LTD·Filed 2014·Application pending·0 cites
- 2233US2013203721A1Taste-masked powder for suspension compositions of methylprednisoloneBHUTADA PRAVIN MEGHRAJJI·Filed 2011·Application pending·0 cites
- 2333US2013142849A1Controlled release formulations of dronedaroneDESHMUKH ASHISH ASHOKRAO·Filed 2011·Application pending·0 cites
- 2431US2013143897A1Oral controlled release pharmaceutical compositions of blonanserinBHUTADA PRAVIN MEGHRAJJI·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sajeev Chandran files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →